[go: up one dir, main page]

MXPA97006046A - Water-based anti-transparent compositions, quick and non-sticked - Google Patents

Water-based anti-transparent compositions, quick and non-sticked

Info

Publication number
MXPA97006046A
MXPA97006046A MXPA/A/1997/006046A MX9706046A MXPA97006046A MX PA97006046 A MXPA97006046 A MX PA97006046A MX 9706046 A MX9706046 A MX 9706046A MX PA97006046 A MXPA97006046 A MX PA97006046A
Authority
MX
Mexico
Prior art keywords
ppg
antiperspirant
compositions
buteth
composition according
Prior art date
Application number
MXPA/A/1997/006046A
Other languages
Spanish (es)
Other versions
MX9706046A (en
Inventor
Mackles Leonard
Chavkin Leonard
T Larkin Mary
Jorgensen Lise
Original Assignee
Bristolmyers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/700,165 external-priority patent/US5833963A/en
Application filed by Bristolmyers Squibb Company filed Critical Bristolmyers Squibb Company
Publication of MXPA97006046A publication Critical patent/MXPA97006046A/en
Publication of MX9706046A publication Critical patent/MX9706046A/en

Links

Abstract

The invention provides antiperspirant compositions completely based on water, for application on the skin to reduce or inhibit perspiration and the bad smell of the body. The compositions contain blocked polyglycols which function as tackifying agents and / or as emollients, and which provide a completely soluble environment for the antiperspirant active ingredient. The compositions of the invention are stable, readily and economically prepared, and provide versatile formulations which can be supplied and applied to the skin by a variety of means, including rotating bead devices, aerosols, and the like. Without the need for astringent alcoholic emulsions or additives, the technology of the water-based antiperspirant solution of the invention provides compositions that are clear, non-sticky, quick-drying, and leave a small or non-visible residue or film on the skin to continuation of the application

Description

ANTITRANSPIRANT COMPOSITIONS BASED ON WATER, QUICK DRY AND NOT STICKY Field of the Invention The present invention relates in general to the field of antiperspirants and deodorants to reduce and prevent perspiration and the body odor associated with human perspiration, particularly the bad odor of the armpits, without the disadvantageous effects of stickiness or moisture following the application.
Background of the Invention • The antiperspirants fight the bad odors of the armpits by inhibiting perspiration through the action of astringent salts such as aluminum and zirconium salts. As has been experienced by a considerable number of users of the antiperspirants, such active salts can be irritating and painful to the skin or body surface to which it is applied in the first place. Deodorants, on the other hand, prevent objectionable odors that result from the degradation of Ref. 25309 components of the sweat which are attacked by chemical substances and microbes, for which they produce fatty acids of bad odors. Because deodorants do not inhibit sweating, but rather inhibit the growth of microorganisms that cause bad odor, deodorants are generally less irritating to the skin than antiperspirants. However, the action of antiperspirants reduces or prevents moisture and sweating; therefore, antiperspirants are frequently preferred over deodorants. To be effective inhibitors of underarm sweat, antiperspirant salts, which comprise antiperspirants, should be used in high concentrations in the products. These water-soluble salts, in concentrated solutions, are astringent when applied to the skin, and sticky when dry, thus producing an unpleasant sticky feel in the armpits. A variety of product forms have been developed with the sole purpose of solving this problem elegantly.
Originally, solutions for spraying in oppressible bottles were sold, but these were wet and dropping drops of the solutions and reduced little stickiness in the armpits. The creams were less sticky, but required manual application and They left unpleasant looking residue on skin and clothes. The rotating bead emulsion lotions were an improvement, because they were applied directly and provided a thin film of the product, but they were still sticky, dirty or scrambled, and slow drying. In addition, aerosol spray solutions appear to provide an elegant product form, but they supplied a spray, broadly diffused, around the user's face and ultimately were rejected because of the negative environmental impact of the spray. His properties. The stickiness was eliminated by the development of antiperspirant salt suspensions, either in a liquid volatile silicone vehicle applied as a solution for a rotating ball device or in a solid greasy bar that can be rubbed in the armpit area. These forms still have some significant degree of acceptance by the consumer, but they are being rejected by many consumers, particularly women, because of the pulverized, white residue, which is both formed and deposited in the armpit area. This factor is particularly objectionable, since the residue is easily transferred from the armpit and is applied to and visible on the user's clothes while the user is wearing the clothes. The high level of popularity of clear antiperspirant forms attests to the importance of the non-elegant and negative effects mentioned above in the mindset of consumers. However, the development of clear antiperspirant products that are aesthetically pleasing have also evaded the formulator. Common clear products use solvents, cosolvents, and emollients that actually increase the adhesion of the solutions of the antiperspirant salts. Those that are commonly used are water-soluble glycols, such as glycerin, propylene glycol, and sorbitol, or ethanol-like solvents, all of which lead to products that are adhesive and sticky in the armpits, and many of which leave Objectable white residues when they dry. In addition, a number of antiperspirants formulated as high viscous internal phase emulsions or microemulsions and comprising oil-in-water compositions and various additives may show a residue. white after application of the antiperspirant and drying. Such a residue can be attributed to the volatilization of the liquid component, which is usually ethanol at high levels, and fact that leaves a film of non-volatile powdered ingredients underneath. Another problem in the art, especially with those antiperspirant compositions having a significantly elevated alcohol content, is an itching sensation which occurs after application of the product on the skin, particularly after shaving. Clear, or translucent, gelled antiperspirant sticks, which are substantially anhydrous, contain an active antiperspirant material, a stabilizer as an essential component, and are gelled in a gelling agent, such as dibenzylidene monosorbitol acetal, have already been described (US Pat. No. 5,376,363 to AJ Benfatto et al.). However, acetal gelling agents are frequently unstable in the acidic environment of most antiperspirant actives, so suitable buffering or stabilizing agents should be discovered and used to stop the acid attack on the gelling agent. In addition, many of the clear or translucent antiperspirant sticks containing the acetal gelling agent and the solubilized active antiperspirant material have the disadvantage that they are inherently tacky. To further complicate the problems in the art, acid hydrolysis of the gelling agent conventionally used occurs more rapidly in aqueous solutions, so that those skilled in the art have had to use non-aqueous formulations. Other compositions provide antiperspirant active materials in gelling agents of different types, such as the polyamide gelling agent (U.S. Patent No. 5, 500, 209 of M.S. Mendolia et al.). Accordingly, there remains a desired goal in the art for the development of stable, clear antiperspirant products, which provide the following advantageous characteristics: 1) that they do not feel objectionably wet or cold during application; 2) they dry quickly; 3) that do not feel sticky or adherent; and 4) that they do not leave visible residues in the armpit area after the application. The present invention provides fully soluble water-based antiperspirant compositions which can be formulated in all types of liquid delivery or dosage forms. The antiperspirant compositions or formulations of the invention comprise newly discovered classes of emollient solvents that are stable, safe for application to human skin, and uniquely satisfy the criteria described above. The present compositions provide formulations Cosmetically elegant, clear antiperspirants, which are aesthetically acceptable after application, which are not irritating to the user's body and skin, and which are capable of effectively inhibiting perspiration and preventing moisture and odor from the body.
Brief Description of the Invention The present invention provides simple, water-based antiperspirant compositions comprising, in general, one or more antiperspirant salts, polyglycols, preferably blocked polyglycols, water, and, if desired, optional ingredients conventionally used in antiperspirant compositions. The compositions of the invention are suitable for use in a number of different cosmetically manufactured forms, for application on the body and the surface of the skin. The compositions have an excellent efficacy to combat body odor and perspiration and are cosmetically aesthetic. The antiperspirant compositions of the invention are easily applied on the surface of the skin, they dry quickly, and they are not perceived to feel sticky, adherent or sandy, and leave no visible residue after the application. It is an object of the present invention to provide antiperspirant compositions based on water, stable, containing polyglycols for cosmetic use, which very effectively provide non-sticky, water-soluble antiperspirant active materials to the skin, for use in combating perspiration and body odor, for example, in the axillary regions of the human body, applying the antiperspirant compositions to the human body, for example, to the skin in the axillary regions of the body. It is another object of the invention to provide cosmetic compositions of the antiperspirants described above, which do not exhibit stickiness, which feel uniform and dry after application, do not feel greasy or oily, are applied in a clear manner to the skin and they remain clear and clean, that is, they leave no chalky or mealy residue after application, regardless of the ways in which the antiperspirant compositions are delivered (for example, in the aerosol or spinning bead forms, and the like). It is still another object to provide a water-based antiperspirant composition for use in methods to treat or prevent human foul odor associated with perspiration and sweat, especially the bad smell of the armpits. The methods comprise applying to the skin of a human being an effective and safe amount of the antiperspirant compositions of the invention. Still another object of the invention is to provide a water-based antiperspirant solution technology utilizing polyglycols, which minimizes or eliminates stickiness, which dries quickly and which is clear. According to the invention, the technology of the antiperspirant solution is suitable for a wide variety of different delivery forms, has acceptable and advantageous organoleptic qualities, and significantly lower costs than commonly available antiperspirant products, for example, rotating bead products, clear. The technology of the solution of the invention is also economical and easy to manufacture. The additional objects and advantages produced by the invention will be apparent from the detailed description given hereinafter.
Detailed description of the invention The present invention provides water-soluble antiperspirant compositions, completely soluble, to reduce or inhibit sweating and perspiration. In general, . the compositions provide simple and elegant formulations which comprise one or more salts in combination with polyglycols, preferably blocked polyglycols, and water. All of the components of the antiperspirant compositions of the invention are soluble and are in solution in the water-based compositions. The compositions of the invention deposit an effective and adequate amount of the antiperspirant material when the compositions are applied to and rubbed on the skin, for example, in the axillary regions of the body (ie, the compositions have good properties of utility or final result). . Another advantage of the antiperspirant compositions of the invention is that they are simple to produce and avoid the use of multiple phase systems and emulsions. Blocked polyglycols as used herein encompass molecules that are comprised of alternative sections of a chemical composition (eg, PPG) separated by sections of a different chemical nature (e.g., POE). The polyglycols components of the compositions have recently been discovered as novel classes of emollient solvents which have the unique ability, when mixed with aqueous solutions of the popular antiperspirant salts, to form clear solutions which are physically and chemically stable, do not reduce the effectiveness of the antiperspirant salts in the compositions, and do not feel moist during application to the skin. Furthermore, the glycols formulated in the antiperspirant compositions of the invention serve to reduce or eliminate the moisture and tackiness of antiperspirants and do not produce visible residues in the axilla when they are sprayed and dried during application. In addition, these novel compositions do not cause itching or burns during application, and do not increase the irritation of antiperspirant salts in the compositions, in contrast to ethanol. According to the invention, novel antiperspirant compositions comprising polyglycols or need to contain significant amounts of alcohol components. The presence of polyglycols in the antiperspirant compositions of the invention leads to minimization, reduction, or elimination of tackiness. Accordingly, polyglycols, for example, PPG-2-Buteth-3, serve as tackifying agents in the final compositions described herein. In addition, such polyglycols can also function as emollients for the improvement of the organoleptic qualities of the compositions of the invention. invention. It is believed that stickiness can be attributed to an abundance of hydroxyl groups, mainly in the active antiperspirant and aqueous components, but also in the excipient ingredients of the antiperspirant compositions. An excess of hydroxyl groups, in turn, causes a subsequent binding of hydrogen on the skin. Non-limiting examples of the typical excipient ingredients in such formulations which are believed to be associated with the hydrogen bonding of the skin, mentioned above, are glyceryl monostearate stabilized with acid, sodium sulfate and lauryl, sodium sulfate and cetyl, triethanolamine sulfate and lauryl, alkyl aryl sulphates, hexitol ethers of the common fatty acids and their polyoxyethylene derivatives, and polyolioxyethylene esters. Accordingly, the presence of the blocked polyglycols in the novel antiperspirant formulations or compositions of the invention was found to minimize the binding of hydrogen and consequently minimize the perception and the degree of stickiness on the skin. Actually, the results of the sensory studies (Example 1) showed very little stickiness after the application of an exemplary formulation of the invention, comprising one or more blocked polyglycols, against a high degree and stickiness perception using a commercially available antiperspirant formulation (eg, Ban Roll-on) based on an emulsion. Generally speaking, polyglycols for use in the invention are included as elements of the class of polyethylene or polyethylene oxide derivatives, for example, linear polymers of ethylene or propylene oxides having the general formula: CH, I RO- [CH: CHO]. [CH, CHJO]. - H where m can be 0; however, m is generally greater than n; for example, n from 1 to approximately 34, preferably 2 to 20; and m has an average value from about 2 to 45, preferably 3 to 30; and R is an alkyl, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, hexyl, and the like, glyceryl, or H whenever n > 2, preferably n > 6. Water-soluble, liquid-blocked polyglycols are currently preferred in the compositions of the invention. More particularly and in a non-limiting sense, polyglycols based on butanol (ie, buteth), having a chain length as shown in the following formula: C < H, (OCHCH. (OCH1CH.) And OH, CH, wherein, x varies from an average value of about 2 to 33, and varies from an average value of about 3 to 45, and which are compatible with the active antiperspirant salts (eg, aluminum and zirconium salts), they are employed in the compositions of the invention. In addition, water-soluble polyglycols, which are blocked polymers (blocked polyglycols) having a molecular weight of from about 200 to 20,000, preferably, from about 250 to about 5000, and more preferably in about 270 to 2000, are contemplated for use in the compositions of the invention. The chemical formulas and definitions of a number and variety of blocked polyglycols, suitable for use as emollient solvents in the antiperspirant compositions of the invention, and as further described herein below, are found in the Cosmetic Ingredients Book of the CTFA, Monographs , Second Edition, Eds. John A. Wenninger and G.N. McEwen, Jr., Ph.D., J.D., Washington, D.C., 1992, which is known to those skilled in the art. technique, and the content of which is incorporated herein for reference. Examples of the particular polyglycols for use in the invention include, but are not limited to, those which are commercially available as fluids and lubricants from Union Carbide under the trademark designation UCON®. Such UCON compounds suitable for use in the invention, and their solubilities in various solvents at 25 ° C, are described in the books / brochures of the products, standards of "Fluid and Lubricants UCON®", which are incorporated herein by reference . It will be understood by those skilled in the art that UCON® products also correspond to a more general designation of the polyglycol chemical compounds known in the art. As a particular example of several name designations which define the same compound, the 50-HB-55 product of UCON® is also known as PPG-2-Buteth-3; PPG-2-Buteth-3, in turn, is also known in the art as polyoxyethylene (3) polyoxyethylene monobutyl ether and (2) polyoxypropylene monobutyl ether polyoxyethylene (3), as described in US Pat. Cosmetic Ingredients Book of the CTFA. Non-limiting examples of water-soluble polyglycols for use in the compositions novel antiperspirants of the invention include UCON® polyglycols of the 50-HB series of fluids and lubricants which comprise the chemical structures of the starting polymer of the alcohol containing equal amounts by weight of the oxyethylene and oxypropylene groups and which they have a terminal hydroxyl group. Such exemplary UCON® 50-HB compounds have a range of molecular weights and viscosities, and all are soluble in water. More particularly, a preferred polyglycol, called UCON® 50-HB-55 (also known as PPG-2-Buteth-3), has a molecular weight of 270; UCON® 50-HB-100 (also known as PPG-3-Buteth-5) has a molecular weight of 400; UCON® 50-HB-170 (also known as PPG-5-Buteth-7) has a molecular weight of 730; UCON® 50-HB-260 has a molecular weight of 1000; UCON® 50-HB-400 has a molecular weight of 1200; UCON® 50-HB-660 has a molecular weight of 1700; UCON® 50-HB-2000 has a molecular weight of 2900; UCON® 50-HB-3520 has a molecular weight of 3200; and UCON® 50-HB-5100 (also known as PPG-33-Buteth-45) has a molecular weight of 4000. Another class of exemplary, but non-limiting polyglycols, for use in the compositions of the invention, includes the series of fluids and lubricants UCON® 75-H, which are a class of polymers initiated from polyol, soluble in water, which they have two terminal hydroxyl groups (R = H). These polymers contain 75 weight percent oxyethylene and 25 weight percent oxypropylene groups. Specific but non-limiting examples of the 75-H fluids usable in the compositions of the invention include: UCON® 75-H-450 having a molecular weight of 1050; 75-H-1400 which has a molecular weight of 2500; 75-H-90,000 having a molecular weight of 12,000; and 75-H 1400. Other examples of polyglycols suitable for use in the compositions of the invention include, but are not limited to, polypropylene glycol (17) or PPG-17; polypropylene glycol P-2000 or PPG-26; polypropylene glycol 4000 or PPG-30; PPG-9 (or Witconol PPG-400); PPG-34; PPG-10 butanediol; PPG-12-Buteth-16; PPG-15- Buteth-20; PPG-20-Buteth-30; PPG-24-Buteth-27; PPG-26- Buteth-26 (also known as Witconol APEB); PPG-28- Buteth-35; and PPG-2 Methyl Ether. For reasons of convenience and clarity, Table 1 shows a number of exemplary blocked polyglycols for use in accordance with the invention and described by their CTFA designations, technical names, and registered names.
Table 1 CTFA Designation Technical Name Registered Name PPG-9 polyoxypropylene (9) Witconol PPG-400 (Witco) polypropylene glycol (9) PPG-17 polyoxypropylene (17) polypropylene glycol (17) PPG-26 polyoxypropylene (26) Hodag PPG 2000 (Calgene) polypropylene glycol (26) PPG-30 polyoxypropylene (30) Polyglycol P-4000 (Dow) polypropylene glycol (30) PPG-34 polyoxypropylene (34) Witconol CD-17 (Witco) polypropylene glycol (34) PPG-10 Butandiol Probutyl DB-10 (Croda, Inc.) PPG-2 Methyl Ether Dipropylene Glycol Dowanol DPM Monometic Ether (Dow Chemical) PPG-4 Polyoxypropylene atylous ether (4) butyl ether polypropylene glycol (4) butyl ether PPG-5 Butyl Ether Polyoxypropylene (5) Butyl Ether UCON Lubricant LB-65 Polypropylene Glycol (5) (Union Carbide) Butyl Ether PPG-9 Butyl Ether Polyoxypropylene (9) Butyl Ether UCON Lubricant LB-13 Polypropylene Glycol (9) (Union Carbide) Butryl Ether PPG-14 Ether butyliso polyoxypropyl ene (14) butyl ether Fluid? P (Amerchol) polypropylene glycol (14) butyl ether PPG- 15 Butyl ether polyoxypropylene (15) butyl ether UCON Lubricant polypropylene glycol LB-285 (Union Carbide) (15) butyl ether PPG-16 Butyl ether polyoxypropylene (16) butyl ether Hodag PB-300 polypropylene glycol (Calgene) (16) butyl ether PPG-2 Buteth-3 polyoxyethylene (3) polyoxypropylene (2) monobutyl ether UCON Lubricant polyoxyethylene (2) 50-HB-55 polyoxypropylene (3) monobutyl ether (Union Carbide) PPG-3 Buteth-5 polyoxyethylene (5) polyoxypropylene (3) oleobutyl ether UCON Lubricant polyoxyethylene (3) polyoxypropylene (5) 50-HB-100 monobutyl ether (Union Carbide) PPG-5 Buteth-7 polyoxyethylene (5) polyoxypropylene (7) ether UCON Lubricant monobutyl 50-HB-170 (Union Carbide) PPG-9 Buteth-12 polyoxyethylene (9) polyoxypropylene (12) monobutyl ether 50-HB-400 polyoxyethylene (12) polyoxypropylene (9) (Ai? Erchol) monobutyl ether PPG- 12 Buteth-16 50-HB-660 (Amerchol) PPG- 15 Buteth-20 polyoxyethylene (20) polyoxypropylene (15) monobutyl ether polyoxyethylene (15) polyoxypropylene (20) monobutyl ether PPG-20 Buteth-30 polyoxyethylene (20) polyoxypropylene (30) polyoxyethylene monobutyl ether (30) polyoxypropylene (20) monobutyl ether 50-HB-2000 (Amerchol) PPG-24 Buteth-27 polyoxyethylene (24) "polyoxypropylene (27) monobutyl ether Tergitol XD po i i i i i i et i no (27) Surfactant psiloxypropylene (24) monobutyl ether (Union Carbide) PPG-26 Butelh-26 polyoxyethylene (26) polyoxypropylene (26) Witconol APE monobutyl ether (Witco) PPG-28 Buteth-35 polyoxyethylene (28) polyoxypropylene (35) monobutyl ether UCON Fluid polyoxyethylene (35) polyoxypropylene (28) 50-HB-352 monobutyl ether (Amerchol) PPG-33 Bllteth-45 polyoxyethylene (33) polyoxypropylene (45) monobutyl ether UCON Fluid polyoxyethylene (45) polyoxypropylene (33) 50-HB-510 monobutyl ether (Amerchol) Several examples of the blocked polyglycols, which are not soluble in water, but which could be used in the compositions in suitable amounts under the appropriate conditions and with the appropriate amounts of the other component ingredients, include PPG-4 butyl ether; PPG-5 Butyl Ether; PPG-9 Butyl Ether; PPG-14 Butyl Ether; PPG-15 Butyl Ether; PPG-16 Butyl ether, and the like. The polyglycols are present in the compositions of the invention in an amount effective to solubilize and to reduce or eliminate the perception of stickiness or adhesion of the composition. The polyglycols are present in the final antiperspirant composition in an amount of about 2% to 60% by weight, preferably about 5% to 50% by weight, more preferably, about 10% to 30%, by weight based on in the total weight of the composition. More than one blocked polyglycol can be formulated into the compositions, as exemplified, such that the final antiperspirant formulations contain a mixture or combination of polyglycols of an appropriate effective amount, in% by weight. In one embodiment of the invention, the liquid-soluble, water-soluble polyglycol ethers are formulated in the antiperspirant compositions. Although there are many water-soluble polymers of ethylene oxide, propylene oxide and copolymers of ethylene and propylene oxides, those particularly useful to meet the criterion of producing clear, stable, elegant antiperspirant solutions, in this embodiment, have one of the terminal hydroxyl groups to form an ether. More specifically, such water-soluble polyglycol ethers are methyl, ethyl, butyl or glyceryl ethers of polyethylene, polypropylene or copolymers of ethylene and propylene oxides as hereinafter described: 1) Polyethylene glycol ethers having the formula: CH-3 (0-CH2-CH2) nOH, where n = 6 to 16. Examples of polyethylene glycol ethers for use in this embodiment, include, but are not limited to : CTFA Designation Registered Name PEG-6 Carbowax Methyl Ether MPEG 350 (Union Carbide) PEG-10 Carbowax Methyl Ether MPEG 550 (Union Carbide) PEG-16 Carbowax MPEG 750 (Union Carbide) 2) Polypropylene glycol ethers having the formula: R (OCH2-CH2-CH2) nOH, wherein R = methyl, glyceryl and n = 2 a .
Examples of the polypropylene glycol ethers for use in this embodiment include, but are not limited to: CTFA Designation Registered Name PPG-2 Dowanol methyl ether DPM PPG-3 Dow Polyglycol Glyceryl ether PT 250 PPG-10 Dow Polynlyi.nl glyceryl ether 3) Polyethylene Polypropylene glycol ethers having the formula: R (0-CH 2 -CH 2 -CH 2) x (OCH-CH 2) y OH, wherein R = butyl, x = 2 to 7, and y = 3 to 10. The examples of polyethylene polypropylene glycol ethers for use in this embodiment, include, but are not limited to: CTFA Designation Registered Name PPG-2 Buleth 3 Ucon 50 HB 55 (Union Carbide) PPG-3 Buteth 5 Ucon 50 HB 100 (Union Carbide) PPG-5 Buteth 7 Ucon 50 HB 170 (Union Carbide) PPG-7 Buteth 10 Ucon 50 HB 260 (Union Carbide) Examples of the antiperspirant active compounds, ie the active salts such as the astringent antiperspirant metal salts, the which are suitable for use in the preparation of the antiperspirant compositions according to the invention include, but are not limited to, typical aluminum and aluminum zirconium (Al / Zr) salts, which are familiar to those skilled in the art. More particular examples of the antiperspirant salts include, but are not limited to, aluminum chlorohydrate, sodium aluminum hydrochloride, aluminum sesquichlorhydrate, aluminum hydrobromide, aluminum halides (eg, aluminum chloride), aluminum hydroxyhalides, sodium and aluminum chlorohydroxy lactate, buffered aluminum sulfate, aluminum chlorohydrex, aluminum hydroxide, aluminum oxychloride, aluminum oxysulfate, aluminum and zirconium compounds, such as aluminum-zirconium trichlorohydrex-gly, aluminum-zirconium tetrachlorohydrex-gly, aluminum-zirconium pentachlorohydrex-gly, aluminum-zirconium octachlorohydrex -gly, zirconium-aluminum trichlorohydrate, zirconium-aluminum pentachlorohydrate, zirconium-aluminum tetrachlorohydrate, zirconium-aluminum chloride, zirconium-aluminum sulfate, and potassium aluminum sulfate. Other suitable astringent metal salts include those of zirconium, such as zirconyl oxyhalides, zirconyl hydroxyhalides (eg, zirconium hydroxychloride) and zirconium lactate. The mixtures, complexes and combinations of the antiperspirant metal salts are also suitable for use. The zirconium compounds described in U.S. Pat. No. 4,120,948 to Shelton; in U.S. Pat. No. 3,679,068; and in British Patent Specification No. 2,144,992, Callaghan et al, can be used. The aluminum compounds are described in U.S. Pat. No. 3,887,692, 3,904,741, 4,359,456; and in the specifications of British Patent Nos. 2,048,229 and 1,347,950. In addition, the aluminum and zirconium salts for use in the antiperspirant compositions of the invention can be found by the practitioner and are described in the Cosmetic Ingredients Book of the CTFA, Monographs (1992), for example, on pages 15- 20. Non-limiting examples of the aluminum and zirconium salts that are currently preferred in the compositions of the invention are available from the chemical company Reheis Inc., particularly, the aluminum-zirconium complexes commercially available under the trademark designation REACH. ®. The CTFA nomenclature corresponds to the particular REACH® products as follows: the zirconium-aluminum complexes REACH® AZP 701, 902, and 908 are aluminum-zirconium tetrachlorohydrex-gly with respect to the CTFA nomenclature; the REACH® AZZ 902 zirconium-aluminum complex is aluminum-zirconium trichlorohydrex-gly with respect to the CTFA nomenclature; and the zirconium-aluminum complexes REACH®AZ0 902 and 908 are aluminum-zirconium octachlorohydrex-gly with respect to the CTFA nomenclature. The particular characteristics of the REACH series of active antiperspirants are described in Tables 2 and 3, as presented in the REACH® product brochure of Reheis®: Table 2 REACH ® Aluminum Hydrochlorides Table 3 Complexes of Zirconium-Aluminum REACH Another particular but non-limiting example of an aqueous aluminum and zirconium salt which is very suitable for use in the compositions of the invention, is aluminum-zirconium 35% aqueous tetrachlorohydrex-Gly, commercially available as Westchlor® ZR 35B from Westwood Chemical Corporation, Middletown, NY. The Westchlor ZR 35B is a conventional tetrasal with an atomic ratio of Al / Zr of 3.5: 1 and a ratio of metal / chloride 1.4: 1, and is also cyclo-ocid by those skilled in the art as AZG or ZAG. The OTC Panel on Antiperspirants of the Food and Drug Administration has adopted certain nomenclature and specifications for various aluminum and zirconium polychlorohydrates that are useful in the present invention. These are described in Table 4 given below: Table 4 Nomenclature Interval of Interval of Adopted by Proportion of Proportion of the Panel Metal-Halide Al / Zr Trichlorhydrate below 2.1 but above 2.0 pe-of aluminum and not including 1.5: 1 ro without including zirconium 6.0: 1 Tetrachlorohydrate down from 1.5 up to 2.0 aluminum and not including 0.9: 1 but not including zirconium 6.0: 1 Pentachlorohydrate down from 2.1 up to 6.0 of aluminum and but not including up to and include and zirconium 1.5: 1 do 10.0: 1 Table 4 (Cont.) Octachlorohydrate down from 1.5 up to 6.0 of aluminum and e including 0.9: 1 up to and include zirconium 10.0: 1 It will be appreciated by those skilled in the art that glycine can be bound in the aluminum-zirconium complexes of the antiperspirant active metal salt. In the compositions of the invention, aluminum-zirconium complexes containing glycine are currently preferred. Another non-limiting example of the aluminum metal salt suitable particularly for use in the compositions of the invention is aluminum chlorohydrate, which may be represented by the formula: [A12 (0H) JC1", where m + n = 6, and which covers a range of aluminum to chloride ratios from 2.1 down to but not including 1.9 to 1. Aluminum commercially available hydrochlorides are also preferred under the REACH® trademark designation, as described in Table 2. It will be appreciated by those skilled in the art that products similar to the antiperspirant salts mentioned above are also manufactured by Dow Corning Company. Preferably, in the compositions comprising the antiperspirant salt of aluminum chlorohydrate, an aqueous solution of the antiperspirant (eg, a solution at a concentration of about 50% to 60% in water) can be used. The 50% ACH solution in water can be purchased directly as such from the supplier. The active antiperspirant ingredients are • solubilized in the compositions of the invention in an effective antiperspirant amount to reduce or eliminate perspiration, moisture and bad odor of the body, ie, in an amount sufficient to have an effect of reducing the bad odor of the body by reducing the moisture and the flow of perspiration where it is applied. By reducing the bad odor of the body it is generally understood that there is a minor bad body odor or perspiration moisture after application of the composition to a person's skin, compared to no application on the skin. Such a reduction can be due to a masking of the bad smell, the reduction of the levels of the bacteria which produce the materials that smell bad, for example, of perspiration or sweat, the reduction of perspiration, and the like. In general it is appreciated that the antiperspirant materials act mainly to reduce the bad odor of the body by reducing the production of perspiration or sweat. In general, the active antiperspirant (e.g., the metal antiperspirant salt) is present in the compositions in amounts that are the same as those normally used in the antiperspirant compositions. Typically, the amount is on an active basis and can be from about 2% to about 60% by weight of the composition, preferably about 5% to about 35%, and more preferably up to about 26%. On an anhydrous basis, the amount of the antiperspirant is commonly in the form of about 5% to about 26%. More particularly, the maximum use level for the ACH is typically up to about 26% by weight, while the maximum use level for the AZG is typically up to about 20% by weight, on an anhydrous basis. For deodorant compositions, the amount of antiperspirant may be less than 8%. The compositions formulated according to the invention may include optional ingredients, in addition of the ingredients detailed above, that is, the antiperspirant metal salts, the blocked polyglycols, and the water, to further improve clarity, structural integrity, antiperspirant performance, cosmetic appearance, or to facilitate manufacture. Exemplary, non-limiting classes of cosmetic ingredients or other additives may optionally be used in the solutions of the aqueous antiperspirant composition of the invention in amounts of from about 0.1% to 40%, preferably in the form of about 0.5% to 20% , more preferably, in about 1% up to 1% by weight. Such optional ingredients include, but are not limited to, emollients; emulsifiers; humectants; detergent and emulsifier intermediates; suspension and dispersion agents; antioxidants; condoms; antimicrobial compounds; buffer solutions; chelating agents; binding agents; cosolvents, solvents, and solubilizing agents; clarifiers and agents that remove stickiness; foam boosters; suspension and dispersion agents; Thickening agents; penetration agents; gelling agents; hardeners; reinforcers; opacifying agents; waxes; dyes; colorants; fragrances; and mixtures or combinations thereof, and other components typically used in antiperspirant formulations. If necessary or desired, the antiperspirant may also, illustratively, include deodorant materials, including, but not limited to, antimicrobial compounds, antioxidants, and deodorant fragrances. In general, the optional additive ingredients currently preferred for the compositions of the invention include, but are not limited to, emollients; suspension and dispersion agents; chelating agents; binding agents; cosolvents, solvents and solubilizers; Lightening agents and agents that remove the stickiness; fragrances; perfumes; and combinations or mixtures thereof. The most preferred optional ingredients include suitable amounts of solvents, cosolvents and solubilizers to provide optimum product clarity, for example, dipropylene glycol or polyethylene glycol or surfactants, for example, Brij 78, in amounts of about 0.1% to 40% by weight; perfumes and colors, in amounts of about 0.1% up to 2% by weight; and antimicrobial compounds in amounts of about 0.01% up to 2% by weight. In addition, the pH of the compositions of the invention is from about 2.5 to 6.5, preferably, from about 3.0 to 5.5, more preferably in approximate form 3.5 to 4.5. A low pH can be attributed to the active metal salts, antiperspirants, used in the compositions, which are acidic in nature. In general, the components and additives formulated in the compositions of the invention are stable in an acid medium and compatible with acids to provide an optimum useful life and stability. Several of the optional ingredients listed above that can be used in the compositions of the invention are more particularly considered here below: Solvents, Cosolvents, and Solubilizers: If desired, relatively small amounts of solvents and cosolvents, other than water, may be formulated in the compositions of the invention, to aid in the solubilization of the component ingredients of the compositions and to provide optimum clarity of the product. The solvents and co-solvents commonly used are selected from aliphatic dihydroxy alcohols, containing from 3 to 5 carbon atoms, and include, for example, dipropylene glycol, 1,3-propylene glycol; 1,2- propylene glycol, 1,3-butylene glycol; 1,4-butylene glycol; and 1,5-dihydroxypentane. By far the most preferred cosolvent in the compositions of the invention is dipropylene glycol. However, aliphatic dihydroxy ethers, containing from 6 to 10 carbon atoms, such as dibutylene glycol, can also be used. Co-solvents are typically employed at concentrations from about 0% to about 40%, preferably in about 10% to 25%, more preferably in about 5% to 15% form. An additional exemplary class of compounds having a solubilizing function in the antiperspirant compositions of the present invention is that of the alkoxylated alcohols, such as ceteareth-15, ceteareth-16, ceteareth-17, ceteareth-18, ceteareth-20, ceteareth- 23, ceteareth-25, ceteareth-27, ceteareth-28, and ceteareth-30, with ceteareth 20 which is especially suitable for the solubilizing function in the compositions of the invention. As is known to those skilled in the art, ceteareths are further described in the Cosmetic Book of the CTFA, 1992. Table 5 lists the CTFA designations, the technical names, and the registered names of the exemplary cosolvents and solubilizers, suitable for use in the invention: Table 5 Lightening Agents and Agents that Remove the Stickiness: The compositions of the invention may contain small amounts of one, or several, emollients, surfactants and other water soluble or insoluble components which may function additionally to increase clarity or as anti-scaling agents to prevent stickiness of the compositions after they have dried on the surface of the skin. The emollients improve the feel of the compositions and the ease with which they can be applied. Emollients include lubricants and other materials used to improve the organoleptic characteristics of an antiperspirant product, as is well known in the art. Actually, in the compositions of the invention the blocked polyglycols serve as effective emollient solvents, by which they avoid other emollient additives, unless desired or necessary, as optional additives in the compositions. In addition, the compositions may optionally contain semipolar products which are soluble or compatible with propylene glycol or dipropylene glycol, which are known to those skilled in the art and which may be used in the practice of the invention. The emollients and liquid, clear, semipolar surfactants can be used to achieve improved clarity under all temperature conditions, if desired. An exemplary class of compounds that 'satisfy the above description are described in U.S. Pat. No. 4,759,924. Certain of these compounds are commercially available under the tradename PPG-5-Ceteth 20 (available as Pocetyl AWS), PPG-3-Myreth-3, PEG-20-Laurate and Poloxamer 335. The following Table 6 lists other semipolar materials. which can be used. They are identified by their registered names, the CTFA Cosmetics Book designation, and the commercial source of the material.
Table 6 Registered Name CTFA Designation Source 1. Arosurf 66-E2 Isosteareth-2 Sherex 2. Arlasslve 200 »Isoceteth-20 ICI 3. Dermol G-76 Glycereth-7-Benzoate Alzo 4. Brij 30 Laureth-4 ICI 5. Arosurf 66PE12 PPG-3 Isosteareth-9 Sherex 6. Cetiol HE PEG-7-Glioeryl Cocoate Henkel 7. Aethoxal B PPG-5-Laureth-5 Henkel 8. Emulgin L PPG-2-Ceteareth-9 Henkel Table 6 (Cont.) 9. Sandoxylate SX-408 PPG-2-Isoceteth-4 Sandoz 10. Sandoxylate SX-424 PPG-2-Isoceteth-12 Sandoz 11. Procetyl AWS PPG-5-Ceteth-20 Croda PPG-3-Myreth-3 Other useful materials having the desired properties which may be optionally employed in the compositions of the invention, include diisopropyl sebacate, myristyl lactate and isopropyl myristate. Lightening agents and tackifiers can typically be employed at a concentration level of from about 0.5% to 12%, preferably, about 1% to 10%, more preferably about 1.5% to 8%.
Perfumes and fragrances: The perfumes and fragrances normally employed in cosmetic compositions such as the antiperspirant compositions of this invention may be employed herein if desired. If used, perfumes or fragrances are stable in acidic medium and are typically present in the compositions at a concentration from 0.01% to about 2%, preferably from about 0.05% to 2%.
Antimicrobial compounds: The antimicrobial 'compounds' (for example, the antibacterial compounds) which can be optionally formulated in the compositions of the invention, if desired, will be the same as those which are normally employed in compositions of this nature. Antibacterial compounds include, for example, Triclosan, benzalkonium chloride, benzethonium chloride, and zinc phenosulfate. Typically, the compositions may contain from about 0.01% to about 2% of the antibacterial agent, preferably in about 0.05% to 1.5% form. The compositions may additionally contain coloring agents, botanicals, or other ingredients used in such compositions, provided that such additives are stable in an acidic medium, and are soluble in and compatible with (or can be formulated as such) the other components. in the compositions. An important factor in the stability, clarity, and final organoleptic characteristics of the antiperspirant products of the invention is the compatibility and solubility of various ingredients components of the novel compositions, as described. According to the invention, the components of the final compositions are completely in solution, whereby the technology of the novel and versatile aqueous solution of the invention is created. It will be appreciated by those of skill in the art that the water-based antiperspirant compositions of the invention are effective and useful as common water-based solution formulations, which, in turn, can be formulated in a variety of cosmetic delivery and / or dosage forms for the application and administration of the antiperspirant active materials. Accordingly, according to the invention, water-based antiperspirants can be manufactured / produced in the following forms, which are not proposed to be limiting: creams; gels; solids (for example, a barrier package, a clear bar); sprinklers (for example, sprinklers equipped with a pump); aerosols (for example, a true or legitimate clear spray); rotating ball devices (for example, for faster-spinning spinning ball devices); rotating ball devices with opacifying substances; foams and similar. Although it is not a requirement for its use, the preferred modes of application of the compositions antiperspirants of the invention are as rotating bead devices, sprinklers, or aerosols. The final antiperspirant products comprising the compositions of the invention are preferably clear during application and drying, ie, transparent with respect to the transmission of light, such that minimal white debris or film is visible on the skin on the application site. If the antiperspirant solutions of the invention had to be formulated in a solid or gelled form, they would preferably allow a sufficient amount of light to pass transversely to make it possible for an observer to see without difficulty an image, for example, the letters, which are placed directly below and in contact with the solid or gel form. In general, the process by which water-based antiperspirant compositions are formulated is as follows: 1. The antiperspirant metal salt solution is mixed with water; 2. The other liquid components are added while mixing at room temperature; and 3. The solid solubilizer is melted with the perfume at 50 ° C and is added to the mixture while stirring. The process of preparing the compositions is efficient, easy, and is very suitable for those present aqueous formulations of the invention. More particularly and with respect to the formulation of the ingredients of the components as exemplified herein, the process essentially involves heating the solubilizer, for example, ceteareth-20, as in Examples 9 and 10, at about 50 ° C until it melts. After this, the other components of the composition are mixed at room temperature in the following order; first, the antiperspirant metal salt, for example, ACH; then the deionized water; then the blocked polyglycol anti-splint agent and the emollient, for example, PPG-2-Buteth-3; then the solvent, for example, dipropylene glycol; and then, the blocked polyglycol emollient, for example, PPG-9 (Witconol PPG-400). While these ingredients are being mixed, the molten solubilizing agent (ceteareth) is added and mixing is continued at room temperature until the ceteareth is completely dissolved (ie, for about 30 minutes). It will be appreciated by those skilled in the art that the blocked polyglycol of PPG-9 can be added prior to the addition of the blocked polyglycol of PPG-2-Buteth-3, without adverse effects and with the same resulting composition. The process of formulating the 'compositions is virtually the same for the whole of the antiperspirant compositions according to the invention. The antiperspirant compositions of this invention when tested to verify their effectiveness substantially as described in Federal Register, Vol. 47, Number 162, August 20, 1982, are as active as commercially available compositions and are optically clear (i.e. , transparent), quick-drying and non-sticky for the user.
EXAMPLES The examples described herein are given by way of illustration only and are not to be construed as limitations of this invention, many obvious variations of which may be made without departing from the spirit or scope thereof.
Example 1 A typical sensory study to evaluate each of the antiperspirant compositions prepared as described in the Examples given hereinafter is generally carried out as described in this Example.
More particularly, protective antiperspirant evaluations are completed by a total of eight panelists during the course of several test sessions, depending on the number of samples of the composition being tested. In the case of four pairs of compositions, four test sessions are used. For example, for samples A-H, the pairs tested are A / B; CD; E / F; and G / H. All samples are presented in pairs, but not all panelists received the same pair in a given session; some panelists tested the A / B pair, while others tested the C / D, E / F, or G / H pairs. In addition, the order of presentation of the samples within each pair is random to minimize the position deviation (eg, A / B, B / A). The antiperspirant products of the sample are applied according to the following protocol: • Director of the designated panel uses an automatic pipette to distribute 0.4 ml of the product. To each of the four sites along a marked area of . 24 cm (6 inches) x 5.08 cm (2 inches) over the palmar forearm, 0.1 ml of the product is distributed. A sample is distributed to the left arm and the second sample is distributed to the right arm. Each of the panelists then applies the product using the index finger (protected by a thimble for the finger) in four upwards, which distributes the product over the evaluation area. The evaluations are made immediately after the application and at intervals of 5, 10 and 20 minutes after this. All the marks or evaluations were carried out on an intensity scale of 100 points from 0 = "nothing in total" to 100 = "a lot". Higher evaluations indicate the presence of more of the particular characteristic that is evaluated. The organoleptic characteristics and aesthetic character of the product are evaluated as defined by the touch on the residual skin and appearance. Specifically, the characteristics of the sample evaluated included, for example, gloss, stickiness or adhesion, (in the folds), stickiness or adhesion (tactile), oil, grease, wax, visible white debris, total waste (tactile), stiffness, whiteness that can be removed by rubbing, opacity, and slippage. Particularly with respect to the evaluation of tackiness, a sample product is routinely evaluated to verify stickiness when the product is dried on the skin after application, for example, as a deodorant applied with a rotating ball device. The evaluator determines the feeling of stickiness or adhesion of the finger product and the feeling of stickiness on the skin when the product is dried after application, for example within the course of up to one minute, preferably within 5 to 30 seconds after application. In general for the compositions of the invention, the faster the composition dries on the skin after application, the less amount of tackiness is discerned or perceived by the evaluator in the sensory test. * The results of a comparison of a sensory test between a commercial emulsion product, common, for example, the Ban Roll-on, and the antiperspirant composition of the invention presented in Table 7, used as a test sample and applied by The mean of a rotating ball is described in Table 8. In Table 7, the numbers in parentheses after each of the characteristics listed on the left side of the Table indicate the minutes after a sample was applied.
Table 7 Pirate antitranspository device of the ball device,. , ... ". ,to . rotating value the Ipvencane of p (E-tulsian) Brightness (5) 0.0001 73.1. 6.3 Waste I such (visual) (5) 0.0005 39.4 18.4 Stickiness (folds) (5) 0.0003 14.9 0.4 Humidity (5) 0.01 13.0 0.0 Stickiness (tactile) (5) 0.0001 17.4 1.? Tbtal waste (tactile) (5) 0.04 26.9 18.1 Mat. Particles (5) 0.001 0.7 15.0 Fat (5) 0.02 18.1 1.9 Gloss (10) 0.04 29.0 1.4 Glue (folds) (10) 0.04 8.8 0.0 Arenosity (10) 0.04 25.6 22.5 Occlusion (20) 0.005 15.1 10.6 White waste (visual) (20) 0.004 23.8 6.4 Opacity (20) 0.02 18.4 7.3 Whiteness that can be 0.05 68.8 37.5 Remove by rubbing (20) The antiperspirant formulation of the invention with which the formulation of a commercial rotating bead device was compared in the sensory test described in this Example, is presented in Table 8: Table 8 The results of this comparative sensory test analysis showed that the commercial rotating ball product exhibited significantly higher marks than did the test sample of the invention for all of the significant characteristics, with the exception of the particulate material at 5 minutes. The commercial rotating pellet product was found to be brighter, sticky, moist and oily than the test sample of the invention. The commercial product was determined to leave the skin sense more occluded and sandy and had more visual and tactile residues, which were whiter and more opaque, than the minimum or negligible residues of the test sample. In addition, the commercial rotating ball product produced a significantly greater whiteness that can be removed by rubbing when evaluated at the end of the evaluation period. Accordingly, the antiperspirant compositions of the invention provided more pleasing organoleptic characteristics, more advantageous cosmetic features and more satisfactory personal aesthetic characteristics than the commercially available rotating bead product.
Example 2 The components presented in this Example were mixed as described to prepare an antiperspirant composition of the invention. If the appearance of the composition was clear after the formulation, the composition, as a rotating bead product, was briefly and initially evaluated to verify its organoleptic properties in the laboratory directly after its preparation. Such a first rapid evaluation (ie, an initial organoleptic evaluation) was carried out by applying the product on the skin with three courses from the rotating ball bottle by means of the rotating ball. After approximately 10 seconds, two fingers were used to feel the area over which the composition has been applied to verify the degree of tackiness (adhesion), the speed of drying, the appearance of residues, and the feel of the film.
The appearance of the composition was clear, and the initial organoleptic evaluation determined that the final composition produced a negligible tack.
Example 3 An antiperspirant composition of the invention was prepared by mixing the ingredients presented in this Example.
The appearance of the composition was clear, and the initial organoleptic evaluation determined that the final composition produced a negligible tack.
Example 4 Another composition of the invention was prepared from the components described in this Example, using the procedure used for the Examples described above.
The appearance of the composition was clear, and the initial organoleptic evaluation determined that the final composition was not sticky and dried quickly.
Example 5 The components presented in this Example were mixed as previously described hereinabove to prepare an antiperspirant composition having the advantageous characteristics produced by the invention.
The appearance of the composition was clear, and the initial organoleptic evaluation determined that the final composition was not tacky and produced a negligible amount of residue on the skin.
Example 6 Another composition of the invention was prepared by mixing the following ingredients as described.
The appearance of the composition was clear, and the initial organoleptic evaluation determined that the final composition was sticky in a very small amount and produced waste in a negligible amount.
Example 7 Another composition of the invention was prepared from the ingredients of the components listed below as described herein.
The appearance of the composition was clear, and the initial organoleptic evaluation determined that the final composition was not sticky and dried quickly.
Example 8 A composition according to the invention was prepared from the component ingredients presented in this Example.
The appearance of the composition was clear, and the initial organoleptic evaluation determined that the final composition was not sticky and dried quickly.
Example 9 Another antiperspirant composition was prepared according to the invention from the component ingredients presented in this Example.
The appearance of the composition was clear, and the initial organoleptic evaluation determined that the final composition was only sticky to a minimal degree and produced no white residue.
Example 10 An antiperspirant composition was prepared according to the invention from the component ingredients presented in this Example.
The appearance of the composition was clear, and the initial organoleptic evaluation determined that the final composition had a negligible degree of tackiness and a successfully solubilized fragrance.
Example 11 A composition of the invention was prepared from the components listed below, using the procedure described below.
The appearance of the final composition was clear, and had a negligible degree of tackiness. The composition of this example was prepared as follows: 50% deionized water and aluminum hydrochloride were mixed. Next, PPG-2 Methyl Ether, Methoxy PEG 550, and PPG-2-Buteth-3 were sequenced. All of these components were mixed until a clear solution was obtained. Ingredient number 5, Brij 78, was heated to 50 ° C until it melted. The melted Brij 78 was then added with mixing to the batch combination of the other ingredients. The contents of all patents, patent applications, published articles, books, references, manuals, and abstracts cited herein, is hereby incorporated by reference in its entirety. whole to describe more fully the state of the art to which the invention belongs. Since various changes can be made in the subject matter described above without departing from the spirit and scope of the invention, it is proposed that all subject matter contained in the above description or defined in the appended claims be interpreted as descriptive and illustrative, and not as a limiting sense. Many modifications and variations of the present invention are possible in light of the above teachings. It is therefore to be understood that within the scope of the appended claims, the invention may be practiced in a different manner than specifically described herein.
It is noted that in relation to this date, the best method known by the applicant to carry out the aforementioned invention, is the conventional one for the manufacture of the objects to which it relates.
Having described the invention as above, property is claimed as contained in the following

Claims (23)

1. A clear, soluble antiperspirant composition for application to human skin, characterized in that it comprises an aqueous solution of a metal antiperspirant salt selected from the group consisting of aluminum, zirconium and aluminum-zirconium salts (Al / Zr) in an effective amount to reduce the transpiration and at least one blocked, water-soluble polyglycol, which is a linear polymer of ethylene and / or propylene oxides, the polyglycol has a molecular weight of from about 200 to about 20,000; and is present in the final composition in an effective amount to reduce or eliminate stickiness.
2. The composition according to claim 1, characterized in that the molecular weight of the blocked polyglycol is from about 250 to about 5000.
3. The composition according to claim 1, characterized in that the polyglycol has the general formula I: CH, | (I) RO- [CHJCHO]. [CH_CH_O] ß - H where n has the average value from 1 to about 34; m is 0 or has an average value from about 2 to 45; and R is H whenever n > 2, an alkyl, or glyceryl.
4. The composition according to claim 3, characterized in that R is an alkyl of 1 to 6 carbon atoms.
5. The composition according to claim 3, characterized in that the polyglycol has the general formula II: C4H, (OCHCH _) - (OCH-CH -) - H CH, wherein x has an average value from about 2 to 33, and y has an average value from about 3 to 45.
6. A method for reducing or inhibiting perspiration and body odor of an individual, characterized in that it comprises the step of applying the composition according to any of claims 1 to 5 to the skin of the individual.
7. A water-based antiperspirant composition, characterized in that it comprises by weight, based on the total weight of the composition: a) 2 to 35% antiperspirant of a water-soluble antiperspirant metal salt, selected from the group consisting of salts of aluminum, zirconium and aluminum-zirconium (Al / Zr),. b) about 5% to 50% of at least one water-soluble blocked polyglycol, which is a linear polymer of ethylene and / or propylene oxides having a molecular weight of from about 200 to about 5,000 of the general formula I: CH, I (i) RO- [CH2CHO] B [CHJCHÍO] 1B - H wherein n has an average value from about 1 to 34; m is 0 or has an average value from about 2 to 45; R is H whenever n > 6, an alkyl of 1 to 6 carbon atoms or glyceryl, and c) about 0% to 40% of at least one cosolvent or solubilizer.
8. The composition according to claim 7, characterized in that the polyglycol has the general formula: C4H, (OCHCHI) - (OC? 2CH2) and H CH, where x has an average value from about 2 to 33, and y has an average value from about 3 to 45.
9. The composition according to claim 8, characterized in that the antiperspirant metal salt is selected from the group consisting of aluminum chlorohydrate, aluminum-zirconium trichlorohydrex-gly, aluminum-zirconium tetrachlorohydrex-gly, aluminum-zirconium pentachlorohydrex-gly, aluminum-zirconium octachlorohydrex-g'ly, and aluminum sesquichlorhydrate.
10. The composition according to any of claims 7 to 9, characterized in that the cosolvent or solubilizer is an aliphatic dihydroxy alcohol containing from 3 to 5 carbon atoms or an aliphatic dihydroxy ether containing from 6 to 10 carbon atoms, the cosolvent or solubilizer is present in an amount from 5 to 25%.
11. The composition according to claim 10, characterized in that the cosolvent or the solubilizer is selected from the group consisting of dipropylene glycol, propylene glycol, butylene glycol, ceteareth-15, ceteareth-16, ceteareth-17, ceteareth-18, ceteareth-20, ceteareth -23, ceteareth-25, ceteareth-27, ceteareth-28, and ceteareth-30.
12. The composition according to claim 11, characterized in that the cosolvent or solubilizer is propylene glycol or dipropylene glycol.
13. The composition according to any of claims 1, 3 or 7, characterized in that the blocked polyglycol is selected from the group consisting of PPG-9; PPG-10 Butandiol; PPG-2 Methyl Ether; PPG-5 Butyl Ether; PPG- 9 Butyl Ether; PPG-14 Butyl Ether; PPG-15 Butyl Ether; PPG-16 Butyl Ether; PPG-2 Buteth-3; PPG-3 Buteth-5; PPG-5 Buteth-7; PPG-9 Buteth-12; PPG-12 Buteth- 16; PPG-15 Buteth-20; PPG-20 Buteth-30; PPG-24 Buteth-27; PPG-28 Buteth-35; PPG-33-Buteth-45; and mixtures or combinations thereof.
14. The compositions according to claim 13, characterized in that the blocked polyglycol is a mixture of blocked polyglycols selected from mixtures of PPG-2-Buteth-3 and PPG-9; PPG-2 Methyl Ether and PPG-9; and PPG-9 Buteth-12 and PPG-9.
15. The composition according to claims 1, 3 or 7, characterized in that the blocked polyglycol is selected from the group consisting of PPG-2 Methyl Ether; PPG-3-Glyceryl Ether; PPG-10-Glyceryl Ether, PPG-2-Buteth-3, PPG-3-Buteth-5; PPG-5-Buteth-7, PPG-7-Buteth-10, and mixtures or combinations thereof.
16. The composition according to claim 13, characterized in that the blocked polyglycol is PPG-9-Buteth-12.
17. The composition according to claim 13, characterized in that the blocked polyglycol is PPG-2-Buteth-3.
18. The composition according to claim 13, characterized in that the blocked polyglycol is PPG-2 Methyl Ether.
19. The composition according to claim 7, characterized in that R is an alkyl of 1 to 4 carbon atoms, n = 2 to 12 and m = 3 to 16 or 0.
20. The composition according to claim 7, characterized in that R is glyceryl, n = 2 to 10, and m = 0.
21. The composition according to claim 7, characterized in that R is methyl, m = 6 to 16 and n = 0.
22. The composition according to claim 8, characterized in that x = 2 to 7 and y = 3 to 10.
23. The composition according to any of claims 1 to 22, characterized in that the blocked polyglycol is present in an amount of about 10% to 30% by weight, based on the total weight of the composition. SUMMARY OF THE INVENTION The invention provides antiperspirant compositions completely based on water, for application on the skin to reduce or inhibit perspiration and the bad smell of the body. The compositions contain blocked polyglycols which function as tackifying agents and / or as emollients, and which provide a completely soluble environment for the antiperspirant active ingredient. The compositions of the invention are stable, readily and economically prepared, and provide versatile formulations which can be supplied and applied to the skin by a variety of means, including rotating bead devices, aerosols, and the like. Without the need for astringent alcoholic emulsions or additives, the technology of the water-based antiperspirant solution of the invention provides compositions that are clear, non-sticky, quick-drying, and leave a small or non-visible residue or film on the skin to continuation of the application. ANTITRANSPIRANT COMPOSITIONS BASED ON WATER, QUICK DRY AND NOT STICKY SUMMARY OF THE INVENTION The invention provides antiperspirant compositions completely based on water, for application on the skin to reduce or inhibit perspiration and the bad smell of the body. The compositions contain blocked polyglycols which function as tackifying agents and / or as emollients, and which provide a completely soluble environment for the antiperspirant active ingredient. The compositions of the invention are stable, are prepared easily and economically, and provide versatile formulations which can be supplied and applied to the skin by a variety of means, including rotating bead devices, aerosols, and the like. Without the need for astringent alcoholic emulsions or additives, the technology of the water-based antiperspirant solution of the invention provides compositions that are clear, non-sticky, quick-drying, and leave a small or non-visible residue or film on the skin to continuation of the application.
MX9706046A 1996-08-20 1997-08-07 Non-tacky and quick-drying aqueous-based antiperspirant compositions. MX9706046A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08700165 1996-08-20
US08/700,165 US5833963A (en) 1996-08-20 1996-08-20 Non-tacky and quick-drying aqueous-based antiperspirant compositions

Publications (2)

Publication Number Publication Date
MXPA97006046A true MXPA97006046A (en) 1998-02-01
MX9706046A MX9706046A (en) 1998-02-28

Family

ID=24812433

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9706046A MX9706046A (en) 1996-08-20 1997-08-07 Non-tacky and quick-drying aqueous-based antiperspirant compositions.

Country Status (8)

Country Link
US (1) US5833963A (en)
EP (1) EP0824911A3 (en)
CN (1) CN1184953C (en)
AU (1) AU718470B2 (en)
BR (1) BR9704426A (en)
CA (1) CA2210782C (en)
MX (1) MX9706046A (en)
ZA (1) ZA976830B (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9914498A (en) * 1998-09-23 2001-06-26 Phycogen Inc Safe and effective biopellicle inhibiting compounds and health-related uses thereof
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8715629B2 (en) * 2003-04-16 2014-05-06 Cognis Ip Management Gmbh Cosmetic oligo-α-olefin containing compound
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
GB0525395D0 (en) * 2005-10-28 2006-01-18 Unilever Plc Antiperspirant or deodorant compositions
US20070190089A1 (en) * 2006-02-07 2007-08-16 Leonard Mackles Antiperspirants with water soluble esters
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
WO2008149303A2 (en) * 2007-06-04 2008-12-11 The Procter & Gamble Company Antiperspirant gel composition
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2009090558A2 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
JP5825053B2 (en) * 2010-11-17 2015-12-02 ライオン株式会社 Liquid-based sweat deodorant composition
CN102475660A (en) * 2010-11-29 2012-05-30 吴克 Bromhidrosis eliminating perfume
FR2995785B1 (en) * 2012-09-27 2015-07-31 Oreal ANTI-TRANSPARENT OIL-IN-WATER EMULSION COMPRISING AN ALUMINUM AND / OR ZIRCONIUM ANTI-TRANSPLANTING SALT OR COMPLEX AND A NON-WATER-SOLUBLE FILMOGENIC ETHYLENIC POLYMER AND SEQUENCE
EP3157501A1 (en) 2014-06-23 2017-04-26 Rohm and Haas Company Oil-free emollients in sunscreen compositions
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
WO2019096384A1 (en) 2017-11-16 2019-05-23 Beiersdorf Ag Cosmetic composition with reduced stickiness
EP4146153B1 (en) * 2020-05-07 2023-11-01 Unilever IP Holdings B.V. An antiperspirant composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0404532A1 (en) * 1989-06-23 1990-12-27 The Procter & Gamble Company Antiperspirant compositions
EP0505474B1 (en) * 1989-12-08 1996-10-02 The Gillette Company Antiperspirant
BR9106484A (en) * 1990-05-30 1993-05-25 Procter & Gamble LIQUID ANTIPERSPIRATION COMPOSITIONS
US5376363A (en) * 1991-05-03 1994-12-27 Bristol-Myers Squibb Company Clear gelled antiperspirant stick composition
US5500209A (en) * 1994-03-17 1996-03-19 The Mennen Company Deodorant and antiperspirant compositions containing polyamide gelling agent

Similar Documents

Publication Publication Date Title
US5833963A (en) Non-tacky and quick-drying aqueous-based antiperspirant compositions
MXPA97006046A (en) Water-based anti-transparent compositions, quick and non-sticked
KR100412961B1 (en) Antiperspirant compositions containing 1,2-hexanediol
US5603925A (en) Clear or translucent tack-free antiperspirant stick or gel composition and manufacturing method
AU744353B2 (en) Clear antiperspirant or deodorant gel composition with volatile linear silicone to reduce staining
US5902572A (en) Anhydrous gel deodorant compositions
CA2409239A1 (en) Stable emulsions for cosmetic products
AU2004272034B2 (en) Antiperspirant clear gel with low glycol content
US6083493A (en) Antiperspirant compositions containing isopropyl glycerol ether
AU2005245269B2 (en) Antiperspirant or deodorant compositions
EP1255528A1 (en) Low tack cosmetic composition sticks
AU2001238372A1 (en) Low tack cosmetic composition sticks
EP0531337A1 (en) Liquid antiperspirant compositions
US6531119B1 (en) Compositions with low irritancy
EP1058536B1 (en) Compositions with low irritancy
WO1998043604A1 (en) Transparent aqueous-based roll-on antiperspirant composition
AU2004286773B2 (en) Antiperspirant compositions
AU745662B2 (en) Clear cosmetic gel composition
HK1008488B (en) Non-tacky and quick-drying aqueous-based antiperspirant compositions
MXPA06005253A (en) Antiperspirant compositions
MXPA98001358A (en) Composition of cosmetic gel having irritation of skin reduc
MXPA06007553A (en) Cosmetic composition.